KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis.

scientific article published on 19 December 2017

KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.23456
P932PMC publication ID5787431
P698PubMed publication ID29416688

P50authorSubhash VermaQ57951657
Timsy UppalQ74933559
P2093author name stringSuhani Thakker
Alexandra N Scurry
Roxanne C Strahan
P2860cites workEAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genesQ22253257
Ets-1 and Ets-2 Regulate the Expression of MicroRNA-126 in Endothelial CellsQ24607999
Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cellsQ24629364
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesisQ24656947
KSHV: pathways to tumorigenesis and persistent infectionQ27026000
Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasionQ28472867
Expression and function of Ets-1 during experimental acute renal failure in ratsQ28567782
EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressorsQ33261811
Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.Q33667093
Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.Q33743831
Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cellsQ33779037
Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8Q33814510
Expression and clinical significance of EGFL7 in malignant gliomaQ34102823
Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.Q34548882
KSHV LANA--the master regulator of KSHV latencyQ34774797
Deregulated expression of miR-106a predicts survival in human colon cancer patientsQ34784235
Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcomaQ34980236
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial CellsQ34997083
Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinomaQ35007692
Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cellsQ35111065
Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related OncogenesisQ35124404
Structure and function of latency-associated nuclear antigenQ35124429
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphomaQ35131811
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cellsQ35689577
EGFL7: a unique angiogenic signaling factor in vascular development and diseaseQ35776390
Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1Q35785255
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.Q35809792
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.Q36023151
Kaposi's sarcoma and its associated herpesvirusQ36487309
MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trialQ37185814
KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcriptionQ37237030
VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitroQ37676764
EGFL7 meets miRNA-126: an angiogenesis allianceQ37763307
Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignanciesQ38097263
Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesisQ38160783
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X ComplexQ38903379
Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesisQ38996368
Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.Q39798527
Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesisQ39892759
Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expressionQ40002571
Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implicationsQ40040603
A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxiaQ40106826
Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with DaxxQ40252446
Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infectionQ40598301
Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirusQ40807418
Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditionsQ42049779
Latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus promotes angiogenesis through targeting notch signaling effector Hey1.Q42237356
KSHV Induction of Angiogenic and Lymphangiogenic PhenotypesQ42562294
The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alphaQ42796220
Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 geneQ44033533
The expression of epidermal growth factor-like domain 7 regulated by oxygen tension via hypoxia inducible factor (HIF)-1α activity.Q54179282
The transcription factors hypoxia-inducible factor 1alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritisQ75288502
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)1210-1228
P577publication date2017-12-19
P1433published inOncotargetQ1573155
P1476titleKSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis.
P478volume9

Reverse relations

described by source (P1343)
Q98125572BJAB-L-YFP
Q98125574BJAB-YFP

cites work (P2860)
Q64118066Construction of a High-Density Linkage Map and QTL Fine Mapping for Growth- and Sex-Related Traits in Channel Catfish ()
Q98386232Effects of HPV16 E6 protein on Daxx-induced apoptosis in C33A cells
Q92225761EphA7 Functions as Receptor on BJAB Cells for Cell-to-Cell Transmission of the Kaposi's Sarcoma-Associated Herpesvirus and for Cell-Free Infection by the Related Rhesus Monkey Rhadinovirus
Q92340148In Vivo Models of Oncoproteins Encoded by Kaposi's Sarcoma-Associated Herpesvirus
Q64232572LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency
Q92238951Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus
Q92878849miRNAs and their roles in KSHV pathogenesis

Search more.